A. Amini et al. / European Journal of Pharmaceutical Sciences 9 (1999) 17–24
21
dissipation is insufficient, application of a higher voltage
can produce Joule heating and thereby impair peak res-
olution. However, in our case the lower enantioresolution
areas. The deviation in the peak area of R-ropivacaine is
smaller when it is corrected with the area of the IS.
The effective mobility (m ) of the enantiomers is the
eff
3
D
with the HP
instrument does not depend on zone
sum of two different mobilities (Guttman et al., 1988):
broadening (Table 1), since higher efficiencies were ob-
tained with this instrument.
meff 5 h[rop]/([rop] 1 [rop–CD])jmrop
The differences in migration times of the enantiomers
1
h[rop–CD]/([rop] 1 [rop–CD])jmCD–rop
(6)
3
D
obtained with the Beckman and HP
instruments are
significant at the 95% confidence interval due to the
difference in the applied voltages. The differences in the
migration times and resolution factors between CFT and
the conventional technique under the same conditions were
not significant, however. The variation in separation
performance was greater for the Beckman instrument,
employing CFT for separation of racemic ropivacaine; the
reason for this is not known, but may be due to the
condition of the capillary. There was a tendency towards
higher efficiencies with conventional CE and CFT with the
where [rop] and [rop–CD] are equilibrium concentrations
of the free and complexed ropivacaine, respectively, and
mrop and mCD–rop are the corresponding electrophoretic
mobilities. The selector phase (76 mM) is overloaded by
S-ropivacaine at very high concentration (625 mg/ml ¯2
mM), resulting in a higher free fraction of the enantiomer
and higher effective mobility (shorter migration time),
since mrop . mCD–rop, compare Tables 1 and 2. The availa-
bility of the selector for the other solutes, i.e. R-
ropivacaine and IS, will decrease due to competition with
S-ropivacaine, and their effective mobilities will also
increase. The RMD of the ropivacaine enantiomers de-
creased from 0.033 to 0.008 with increasing concentration
of S-ropivacaine.
3
D
HP
instrument (higher applied voltage) compared to
CFT with the Beckman, but the difference was not
significant. The efficiency was higher in the coated than in
the uncoated capillary owing to the longer migration time
in addition to the smaller electrostatic interaction between
the solute and capillary wall in the coated capillary,
resulting in less zone broadening.
Quantitative determination of the enantiomeric purity of
S-ropivacaine was evaluated by an interlaboratory study
with CFT and conventional CE. R-Ropivacaine was quan-
tified with met-b-CD, as chiral selector, dissolved at a
concentration of 76 mM in the BGE.
3
.2. Enantiopurity analysis of S-ropivacaine
In order to construct calibration curves, R-ropivacaine
(
1.6 to 62.5 mg/ml) was spiked with S-ropivacaine (625
To investigate the repeatability of the migration times
and peak areas the analyte sample, consisting of R-
ropivacaine, S-ropivacaine (625 mg/ml), S-prilocaine (IS,
0 mg/ml), was injected 45 times into a system based on
CFT (Table 2). The concentration of R-ropivacaine was
.1 mg/ml corresponding to 0.5% of the S-enantiomer. The
mg/ml), using S-prilocaine (10 mg/ml) as the internal
standard (IS). The corrected peak areas of R-ropivacaine
and the IS were calculated and the ratio between the areas
was analysed by linear regression. All calibration curves
showed good linearity in the concentration range 1.6–62.5
mg/ml; the numerical data for the linear regression analy-
sis are given in Table 3. There are no significant differ-
ences in the slope of the plots determined by different
methods and instruments and the intercepts were not
significantly different from zero. The lower slope of the
plot obtained with the coated capillary is due to the use of
a different IS: R-mepivacaine (20 mg/ml). The analysis of
S-prilocaine as IS in the coated capillary produced peaks
with areas difficult to determine precisely, resulting in
unreliable calibration curves with low regression factors.
The reason for the fluctuating peak area is not known.
R-Mepivacaine, owing to its migration time (shorter than
that for R-ropivacaine), was shown to be a better IS with
this capillary (Fig. 4). The tailing peak shape of S-
ropivacaine gave a high resolution from the faster migrat-
ing R-enantiomer. The inter- and intra-day precision was
shown to be adequate (Table 4); at the 0.3% impurity level
the reproducibility was .10%.
2
3
results show good precision for migration times and peak
Table 2
Precision data obtained from 45 replicate injections of a solution of
R-ropivacaine (3.1 mg/ml), S-ropivacaine (625 mg/ml) and S-prilocaine
20 mg/ml) as internal standard, employing CFT. Separation conditions:
(
met-b-CD (76 mM) in the BGE, i.e. phosphate buffer pH 3.0 and
3
D
I 5 0.04. Enantioseparation was conducted using a Hewlett-Packard
system equipped with a 48.5 (40 cm effective length)350 mm I.D. fused
silica capillary thermostated at 208C; detection, 214 nm; applied voltage,
0 kV. The capillary was flushed and filled with the chiral solution prior
to application of the analyte sample. During the run both ends of the
capillary were dipped in the BGE. Injection technique: pressure (3.4 kPa
for 5 s)
3
Analysis parameter
Mean value 6RSD%
tmig (R-ropivacaine) 3.1 mg/ml
tmig (S-ropivacaine) 625.0 mg/ml
tmig (S-prilocaine) as IS, 20 mg/ml
Area (R-ropivacaine)
Corrected area (R-ropivacaine) (A1)
Area (S-prilocaine)
8.2261.2 min
8.2961.2 min
9.1061.3 min
3.762611.0
0.45369.9
The LOD was found to be 0.6 mg/ml, corresponding to
a 0.1% impurity level. The lowest concentration of R-
ropivacaine which could be determined with acceptable
precision was 1.6 mg/ml (0.25%) (Fig. 5).
32.27265.0
3.55564.7
Corrected area (S-prilocaine) (A2)
Corrected area ratio A /A
0.12767.6
1
2